
Anthropic's $400M biotech buyout fuels AI drug discovery push
Anthropic acquires Coefficient Bio for $400M, partnering with Novo Nordisk and Bristol Myers Squibb to accelerate AI-driven drug discovery.
News, trends, and insights from the AI frontier.
Latest ByteDance coverage.

Anthropic acquires Coefficient Bio for $400M, partnering with Novo Nordisk and Bristol Myers Squibb to accelerate AI-driven drug discovery.

OpenClaw, an autonomous AI agent, gains traction in China, sparking a market for paid installation services and tech rival products.

ByteDance is developing a 10 trillion-parameter AI model to challenge Anthropic and narrow the AI gap with U.S. rivals.

SoftBank reports a $8.2 billion gain on its Intel stake, while its OpenAI investment shows no change in value.

Tesla launches Doubao AI voice assistant in China while refuting reports of potential sale of its local operations.

Xavier Niel commits his Le Monde stake to a press freedom fund, but his vast AI and media holdings raise questions about concentration.

Alibaba led a $439M Series C round for AI video startup AIsphere, highlighting China's tech giants' push for multimodal AI capabilities.